These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26356692)

  • 1. Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas.
    Yoo YJ; Yang SJ; Hwang HK; Kang CM; Kim H; Lee WJ
    Medicine (Baltimore); 2015 Sep; 94(36):e1404. PubMed ID: 26356692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
    Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
    Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
    Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of standard distal pancreatectomy and splenectomy with radical antegrade modular pancreatosplenectomy.
    Trottman P; Swett K; Shen P; Sirintrapun J
    Am Surg; 2014 Mar; 80(3):295-300. PubMed ID: 24666872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
    Partelli S; Gaujoux S; Boninsegna L; Cherif R; Crippa S; Couvelard A; Scarpa A; Ruszniewski P; Sauvanet A; Falconi M
    JAMA Surg; 2013 Oct; 148(10):932-9. PubMed ID: 23986355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of radical antegrade modular pancreatosplenectomy with conventional distal pancreatectomy for pancreatic adenocarcinoma of the body and tail].
    Yin J; Huang XM; Lu ZP; Zhang K; Wu PF; Xu D; Dai CC; Wu JL; Gao WT; Wei JS; Guo F; Chen JM; Jiang KR; Miao Y
    Zhonghua Wai Ke Za Zhi; 2020 Jul; 58(7):505-511. PubMed ID: 32610419
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
    Fernández-Cruz L; Blanco L; Cosa R; Rendón H
    World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatectomy for left-sided pancreatic cancer: findings of a multicenter, retrospective, propensity score matching study.
    Kim HS; Hong TH; You YK; Park JS; Yoon DS
    Surg Today; 2021 Nov; 51(11):1775-1786. PubMed ID: 33830293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
    Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
    Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive versus open distal pancreatectomy for resectable pancreatic neuroendocrine tumors: A propensity score matched multicentric comparative French study.
    Addeo P; de Mathelin P; Doussot A; Durin T; Canali G; Marchese U; Sauvanet A; Dokmak S; Cherkaoui Z; Fuks D; Laurent C; André M; Ayav A; Magallon C; Turrini O; Sulpice L; Robin F; Bachellier P; Souche FR; Bardol T; Perinel J; Adham M; Tzedakis S; Birnbaum DJ; Facy O; Gagniere J; Gaujoux S; Tribillon E; Roussel E; Schwarz L; Barbier L; Regenet N; Iannelli A; Regimbeau JM; Piessen G; Truant S; El Amrani M
    Surgery; 2024 Aug; 176(2):433-439. PubMed ID: 38797604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spleen and splenic vessel preserving distal pancreatectomy for bifocal PNET in a young patient with MEN1.
    Conrad C; Schwarz L; Perrier N; Fleming JB; Katz MH; Aloia TA; Vauthey JN; Lee JE
    Surg Endosc; 2016 Oct; 30(10):4619. PubMed ID: 26721691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma.
    Ashfaq A; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
    J Gastrointest Surg; 2014 Nov; 18(11):1929-35. PubMed ID: 24916590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort.
    Bolm L; Nebbia M; Wei AC; Zureikat AH; Fernández-Del Castillo C; Zheng J; Pulvirenti A; Javed AA; Sekigami Y; Petruch N; Qadan M; Lillemoe KD; He J; Ferrone CR;
    Ann Surg; 2022 Sep; 276(3):522-531. PubMed ID: 35758433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of lymph node metastasis in pancreatic neuroendocrine tumor.
    Taki K; Hashimoto D; Nakagawa S; Ozaki N; Tomiyasu S; Ohmuraya M; Arima K; Kaida T; Higashi T; Sakamoto K; Sakata K; Okabe H; Nitta H; Hayashi H; Chikamoto A; Beppu T; Takamori H; Hirota M; Baba H
    Surg Today; 2017 Sep; 47(9):1104-1110. PubMed ID: 28229300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes.
    Lee SH; Kang CM; Hwang HK; Choi SH; Lee WJ; Chi HS
    Surg Endosc; 2014 Oct; 28(10):2848-55. PubMed ID: 24853839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
    Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
    Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies.
    Hijioka S; Yamashige D; Esaki M; Honda G; Higuchi R; Masui T; Shimizu Y; Ohtsuka M; Kumamoto Y; Katanuma A; Gotohda N; Akita H; Unno M; Endo I; Yokoyama Y; Yamada S; Matsumoto I; Ohtsuka T; Hirano S; Yasuda H; Kawai M; Aoki T; Nakamura M; Hashimoto D; Rikiyama T; Horiguchi A; Fujii T; Mizuno S; Hanada K; Tani M; Hatori T; Ito T; Okuno M; Kagawa S; Tajima H; Ishii T; Sugimoto M; Onoe S; Takami H; Takada R; Miura T; Kurita Y; Kamei K; Mataki Y; Okazaki K; Takeyama Y; Yamaue H; Satoi S;
    Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1416-1426.e5. PubMed ID: 38615727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of pancreatic neuroendocrine tumors.
    Kimura W; Tezuka K; Hirai I
    Surg Today; 2011 Oct; 41(10):1332-43. PubMed ID: 21922354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.